CAS 52691-62-0|lysophosphatidylcholine O-16:0/0:0
| Common Name | lysophosphatidylcholine O-16:0/0:0 | ||
|---|---|---|---|
| CAS Number | 52691-62-0 | Molecular Weight | 481.647 |
| Density | / | Boiling Point | / |
| Molecular Formula | C24H52NO6P | Melting Point | / |
| MSDS | USA | Flash Point | / |
Names
| Name | 1-o-hexadecyl-sn-glycero-3-phosphocholine |
|---|---|
| Synonym | More Synonyms |
lysophosphatidylcholine O-16:0/0:0 BiologicalActivity
| Description | Lyso-PAF C-16 is a substrate of lysoplasmalogen (LysoPls)-specific phospholipase D (LysoPLD). Lyso-PAF C-16 selective acetylates with arachidonic acid[1][2]. |
|---|---|
| Related Catalog | Research Areas >>OthersSignaling Pathways >>Others >>Others |
| References | [1]. Venable ME, et al. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation. J Biol Chem. 1993 Apr 15;268(11):7965-75. [2]. Yamaura S, et al. Novel enzymatic method for assaying Lp-PLA2 in serum. Clin Chim Acta. 2018 Jun;481:184-188. |
Chemical & Physical Properties
| Molecular Formula | C24H52NO6P |
|---|---|
| Molecular Weight | 481.647 |
| Exact Mass | 481.353210 |
| PSA | 97.86000 |
| LogP | 3.23 |
| InChIKey | VLBPIWYTPAXCFJ-XMMPIXPASA-N |
| SMILES | CCCCCCCCCCCCCCCCOCC(O)COP(=O)([O-])OCC[N+](C)(C)C |
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Risk Phrases | R10;R21 |
| Safety Phrases | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2923900090 |
Customs
| HS Code | 2923900090 |
|---|---|
| Summary | 2923900090 other quaternary ammonium salts and hydroxides。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
Articles4
More Articles| Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. Biochim. Biophys. Acta 837 , 52, (1985) 1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine (alkylacetyl-GPC; platelet-activating factor; PAF) is actively taken up and metabolized by rat alveolar macrophages maintained in culture. The major metabo... | |
| Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. J. Mol. Cell. Cardiol. 20(6) , 547-61, (1988) Myocardial injury was produced in separated groups of anesthetized rabbits by occlusion of the left circumflex coronary artery for 1 h followed by reperfusion for 2, 4, or 6 h after release of the occ... | |
| Metabolism of platelet activating factor (PAF) and related ether lipids by neonatal rat myocytes. J. Lipid Mediat. 1(2) , 113-23, (1989) Suspensions of neonatal rat myocytes were used to investigate the metabolism of [3H]PAF (1-alkyl-2-acetyl-(sn-glycero-3-phosphocholine) (GPC] and [3H]alkyllyso-GPC. [3H]Alkylacyl-GPC consisting of mol... |
Synonyms
| LYSO-PAF16 |
| Ethanaminium, 2-[[[(2R)-3-(hexadecyloxy)-2-hydroxypropoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |
| 1-hexadecyl-sn-glycero-3-phosphocholine |
| 1-hexadecyl |
| 1-O-hexadecyl lyso PAF |
| C16 LYSO PAF |
| 1-O-hexadecyl lyso platelet-activating factor |
| 1-O-PALMITYL-SN-GLYCERO-3-PHOSPHOCHOLINE |
| lysophosphatidylcholine O-16:0/0:0 |
| 1-O-hexadecyl-2-lyso-sn-glycero-3-phosphocholine |
| (2R)-3-(Hexadecyloxy)-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate |
| 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine |
| LYSO-PLATELET ACTIVATING FACTOR |
| MFCD00042932 |
| 1-alkyl-2-hydroxy-sn-glycero-3-phosphocholine |
| LYSO-PLATELET ACTIVATING FACTOR-16 |
| 1-Hexyldecyl-sn-glycerol-3-phosphorylcholine |
